Home › Funds › WEDGE CAPITAL MANAGEMENT L L P/NC › RPRX

WEDGE CAPITAL MANAGEMENT L L P/NC position in RPRX

ROYALTY PHARMA PLC · Health Care

WEDGE CAPITAL MANAGEMENT L L P/NC reported holding 726,068 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$42.4M, representing 0.74% of its reported portfolio and ranking #29 among its reported holdings. WEDGE CAPITAL MANAGEMENT L L P/NC has disclosed RPRX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)726.07K sh
Reported value held$42.37M
Portfolio Weight0.74%
First reportedQ1 2025
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How WEDGE CAPITAL MANAGEMENT L L P/NC's RPRX position evolved

WEDGE CAPITAL MANAGEMENT L L P/NC first disclosed a stake in RPRX in Q1 2025 at 1,014,799 shares (US$31.6M). The position peaked in Q2 2025 at 1,214,921 shares, worth US$43.8M. Across 7 filings, WEDGE CAPITAL MANAGEMENT L L P/NC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 726,068 shares valued at US$42.4M — a reduction of -44,354 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.01M $31.59M New
Q2 2025 1.21M $43.77M Add
Q3 2025 1.19M $42.07M Reduce
Q4 2025 1.04M $40.18M Reduce
Q1 2026 890.84K $42.73M Reduce
Q2 2026 770.42K $43.20M Reduce
Q3 2026 726.07K $42.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has WEDGE CAPITAL MANAGEMENT L L P/NC held RPRX?

WEDGE CAPITAL MANAGEMENT L L P/NC has disclosed RPRX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is WEDGE CAPITAL MANAGEMENT L L P/NC's current position in RPRX?

As of Q3 2026, WEDGE CAPITAL MANAGEMENT L L P/NC holds 726.07K shares of RPRX (ROYALTY PHARMA PLC), valued at $42.37M, representing 0.74% of its reported portfolio and ranking #29.

Has WEDGE CAPITAL MANAGEMENT L L P/NC been buying or selling RPRX?

In the latest 13F filing (Q3 2026), WEDGE CAPITAL MANAGEMENT L L P/NC reduced its position in RPRX. The position peaked in Q2 2025 at 1.21M shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.